Jeffrey T. Walsh, Chief Strategy Officer at bluebird bio, Inc. (BLUE), sold 100 shares at $126.12 ($13K) on 2019-06-18, disclosed to the SEC on 2019-06-20.
Scheduled sale ($13k) by Chief Strategy Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BLUE | SELL | 2019-05-14 | $198K | — | Filing → |
| BLUE | SELL | 2019-04-12 | $298K | — | Filing → |
| BLUE | SELL | 2019-03-13 | $419K | — | Filing → |